Skip to content
Aperlena

TED - Tenders Electronic Daily (Publications Office of the EU) verified 2 days ago Contract award

Belgium - Research and development services and related consultancy services - Development of a rapid point-of-care antimicrobial susceptibility testing diagnostic medical device

€8.8M awarded value · €8,850,000

Key facts

Awarded
Estimated value
€12.9M
€12,860,000
Procedure
Negotiated procedure
  1. Awarded
  2. Published
  3. Contract ends, estimated November 2029
View the official notice Watch this tender

This contract runs about 48 months, so it is back on the market around November 2029. Log in

Awarded to

SHANX MEDTECH B.V.; AIDIAN OY; FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL; BIOSURFIT SA; UNITRON INNOTECH BV

Awarded value
€8,850,000 31% under the estimate of €12,860,000
Award date
Record with this buyer
1 first contract from this buyer in the register
Back on the market
Nov 2029 How we know

When this contract comes back

estimated from the stated duration

This contract runs about 48 months, so it is back on the market around November 2029.

Every contract expiring, on the radar

Summary

Machine-generated summary

The Health and Digital Executive Agency (HaDEA) awarded a research and development contract for a rapid point-of-care antimicrobial susceptibility testing diagnostic medical device. The device should deliver antimicrobial susceptibility results within one hour or less from sample collection, ideally also identifying pathogens from the 2024 WHO bacterial pathogen priority list, Candida spp. or Aspergillus fumigatus. The product had to reach at least TRL 3 and aim for TRL 8 by the end of the contract. The winners were SHANX MEDTECH B.V., AIDIAN OY, Fundacion Para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal, Biosurfit SA and Unitron Innotech BV. The contract was awarded on 2025-11-14 for EUR 8,850,000, which is 31% below the estimated EUR 12,860,000. It lasts 48 months and is expected to end and return to the market around 2029-11-13.

Description

This call for tenders aims to speed up the development of a point-of-care diagnostic medical device that can provide antimicrobial susceptibility results on the bacteria or fungi causing an infection in humans, within one hour or less from subject sample collection, and ideally, to also allow for pathogen identification. Diagnostic tests that allow for pathogen identification (in addition to AST) should aim at identifying at least one of the bacteria listed in the 2024 WHO bacterial pathogen priority list and/or the fungi Candida spp., and/or Aspergillus fumigatus. The call aims to speed up the development of rapid, point-of-care AST devices currently in the pipeline. The proposed product shall be at minimum technology readiness level (TRL) 3 onwards with a clear pathway for CE marking in the EU. By the end of the contract, the product developed should aim at reaching system complete and qualified (TRL 8). Tenders aiming at early TRLs will be considered, as long as the product is working towards certification.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 days ago

What this buyer has paid before

Based on 6 comparable contracts this buyer awarded in this sector over the last 4 years.

This award
€8.8M
Estimated value
€12.9M
Median award
€4.1M
Middle half of past awards
€2.4M to €4.8M

The award is larger than three in four past awards.

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency

Belgium

notices in the register
49
awards
16
awarded in total
€44.1M

Who wins its contracts

Many suppliers
different companies won its awards
16
of the awards went to the three most frequent winners
19%
of its calls state an estimated value
100%

Based on 16 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.

Recent awards

5 open tenders right now

Market context

open now in Research & development
637
median open notice
€294,412

Who wins in this market

Many suppliers

Belgium · Research & development

different companies won awards here
120
of the awards went to the three most frequent winners
5%
buyers awarded contracts here
43

Based on 123 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Similar tenders

Open now

Awarded before

Never miss a tender like this

162 new notices in Research & development in Belgium in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language